诱导多能干细胞用于治疗溶酶体储存障碍
Maryann Lorino1, Bei Qiu1, Brian Bigger1,2
1Centre for Regenerative Medicine, Institute for Regeneration and Repair, the University of Edinburgh, Edinburgh, UK.
Journal of inherited metabolic disease
|July 11, 2025
概括
诱导多能干细胞 (iPSCs) 显示出治疗 lysosomal 疾病 (LSDs) 的前景. 这些干细胞可以在体外模拟LSD,并在体内潜在地再生受损组织.
科学领域:
- 生物医学科学 生物医学科学
- 再生医学是一种再生医学.
- 遗传学 是一个遗传学.
背景情况:
- lysosomal疾病 (LSDs) 是由酶功能障碍引起的罕见代谢疾病,导致基质积累和严重的体和神经症状.
- 目前对LSD的治疗方法无法逆转现有的神经退行,这突出了严重的未满足的医疗需求.
- 神经病性LSD显著影响患者的生活质量,导致认知能力下降和预期寿命缩短.
研究的目的:
- 审查诱导多能干细胞 (iPSC) 技术在研究 lysosomal 疾病中的当前应用.
- 探索iPSCs作为神经病性LSD的再生疗法的潜力.
- 概述iPSCs从疾病建模到临床应用的转化途径.
主要方法:
- 关于iPSC技术及其在 lysosomal 疾病研究中的应用的当前文献的综述.
- 对研究的分析表明基于iPSC的疾病建模用于神经病性LSDs.
- 对基于iPSC的再生疗法的临床前和潜在临床策略的评估.
主要成果:
- 在实验室中,iPSCs可以有效地重复神经病性LSDs的细胞和表型特征.
- 基于干细胞的方法,包括iPSCs,通过替换受损的细胞和神经元,显示出体内再生的潜力.
- 现有的疗法主要集中在预防进一步的损伤,而不是扭转现有的神经病理.
结论:
- 诱导多能干细胞为建模和潜在治疗神经病性溶解体疾病提供了一个有希望的途径.
- 需要进一步的研究和临床转化,才能充分利用iPSCs对LSDs的再生潜力.
- 在寻求有效治疗与LSD相关的破坏性神经疾病的过程中,iPSC技术取得了重大进展.
相关概念视频
01:13Induced Pluripotent Stem Cells
24.4K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.4K
01:21EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:22Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
01:17Stem Cell Culture
5.4K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.4K